Shanon and William Schmidtknecht, of Poynette, filed their lawsuit in federal court in Milwaukee on Jan. 21, a year to the ...

Cole Schmidtknecht, 22, couldn't pay for his daily inhaler due to the “prohibitively expensive” price increase, but then he ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate ... patients to double the dose of their inhaled corticosteroid medication for a ...

Last year saw a key development in the US respiratory diseases market when Mylan finally launched its generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol).

Seretide (salmeterol xinafoate/fluticasone propionate) – sold as Advair in the US and other markets – is the top-selling inhaled beta agonist and corticosteroid combination therapy in the UK.

Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to increase its ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

Interventions: Salmeterol, 42 µg bid via metered-dose inhaler (MDI), and placebo bid via MDI. Measurements and results: Following an interim analysis in 26,355 subjects, the study was terminated ...

Cole Schmidtknecht expected to pay $66.86 for a three-month supply of his preventive asthma inhalers in January 2024 when he ...

As for Inhaler, ‘Open Wide’ was shared today (February 7) and followed yesterday’s release of the final single ‘Billy (Yeah Yeah Yeah)’. “We’ve definitely gotten better at writing songs.

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...